REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 27 filers reported holding REGULUS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $9,250 | +41945.5% | 3,212 | +18794.1% | 0.00% | – |
| Q4 2023 | $22 | -99.6% | 17 | -99.5% | 0.00% | – |
| Q3 2023 | $4,913 | -57.3% | 3,586 | -54.2% | 0.00% | – |
| Q2 2023 | $11,509 | +114990.0% | 7,829 | -33.8% | 0.00% | – |
| Q1 2023 | $10 | 0.0% | 11,831 | +69.0% | 0.00% | – |
| Q4 2022 | $10 | – | 7,002 | +1947.4% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 342 | -85.1% | 0.00% | – |
| Q2 2022 | $5,000 | – | 2,288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 4,263,701 | $7,610,706 | 1.20% |
| Vivo Capital, LLC | 5,000,000 | $8,925,000 | 0.82% |
| CVI Holdings, LLC | 401,012 | $715,806 | 0.62% |
| Opaleye Management Inc. | 1,475,000 | $2,632,875 | 0.60% |
| DAFNA Capital Management LLC | 895,200 | $1,597,932 | 0.38% |
| Deep Track Capital, LP | 3,262,564 | $5,823,677 | 0.17% |
| RA Capital Management | 6,250,000 | $11,156,250 | 0.15% |
| Sarissa Capital Management LP | 185,183 | $330,552 | 0.06% |
| FEDERATED HERMES, INC. | 12,852,654 | $22,941,988 | 0.05% |
| Monashee Investment Management LLC | 197,049 | $351,732 | 0.04% |